Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T R Carroll

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Bioconjugate Chemistry|March 1, 1997
New and versatile ternary ligand system for technetium radiopharmaceuticals: water soluble phosphines and tricine as coligands in labeling a hydrazinonicotinamide-modified cyclic glycoprotein IIb/IIIa receptor antagonist with 99mTcD S Edwards, S Liu, J A Barrett, et al.
Bioconjugate Chemistry|March 1, 1997
Biological evaluation of thrombus imaging agents utilizing water soluble phosphines and tricine as coligands when used to label a hydrazinonicotinamide-modified cyclic glycoprotein IIb/IIIa receptor antagonist with 99mTcJ A Barrett, A C Crocker, D J Damphousse, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 1995
Autoradiography and radioscintigraphy of technetium-99m-sestamibi in c-neu transgenic miceP D Crane, D C Onthank, C R Bourque, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Bioconjugate Chemistry|March 1, 1997
New and versatile ternary ligand system for technetium radiopharmaceuticals: water soluble phosphines and tricine as coligands in labeling a hydrazinonicotinamide-modified cyclic glycoprotein IIb/IIIa receptor antagonist with 99mTcD S Edwards, S Liu, J A Barrett, et al.
Bioconjugate Chemistry|March 1, 1997
Biological evaluation of thrombus imaging agents utilizing water soluble phosphines and tricine as coligands when used to label a hydrazinonicotinamide-modified cyclic glycoprotein IIb/IIIa receptor antagonist with 99mTcJ A Barrett, A C Crocker, D J Damphousse, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 1995
Autoradiography and radioscintigraphy of technetium-99m-sestamibi in c-neu transgenic miceP D Crane, D C Onthank, C R Bourque, et al.
Pageof 2